CXCR2 and cholangiocarcinoma: Triggers Toll-like receptor (TLR) signaling in hepatocytes with induction of CXCL1 and accumulation of CXCR2+ polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), and thereby promotes the development of CCA (Zhang et al., 2021).